| 3. MANUFACTURING OPERATIONS - ACTIVE SUBSTANCES |
Active Substance:DEMECLOCYCLIN HYDROCHLORIDE |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.3 Salt formation / Purification steps: Depuration and crystallisation
|
|
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.2 Cell Culture: Streptomyces Aureofaciens
|
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying, sieving and blending
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:MINOCYCLINE HYDROCHLORIDE |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates Special Requirements: 7.Other: Sancycline, 7-HT and minocycline salt
|
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying, sieving and blending
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:OXYTETRACYCLINE |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.2 Cell Culture: Streptomyces Rimosus
|
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying, sieving and blending
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:OXYTETRACYCLINE HYDROCHLORIDE |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.2 Cell Culture: Streptomyces Rimosus
|
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying, sieving and blending
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:TETRACYCLINE |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.2 Cell Culture: Streptomyces aureofaciens
|
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying, sieving and blending
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:TETRACYCLINE HYDROCHLORIDE |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.2 Cell Culture: Streptomyces aureofaciens
|
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying, sieving and blending
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:OXYTETRACYCLINE CALCIUM |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.3 Salt formation / Purification steps: Depuration, filtration and crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying, sieving and blending
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:LYMECYCLINE |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.3 Salt formation / Purification steps: Crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying, sieving and blending
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:SANCYCLINE |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Crystallization
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying and Granulation
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:SARECYCLINE HYDROCHLORIDE |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates Special Requirements: 7.Other: Iodosancycline; Formylsancycline
|
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Crystallization
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Drying, Granulation and Blending
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|